Foqus Technologies follows Canada’s quantum push to Europe

Introduction

Foqus Technologies, a Canadian quantum‑AI firm, joined the Quantum Trade Mission to Finland and Sweden in October 2023. The delegation, organized by Quantum Industry Canada with backing from Innovation, Science and Economic Development Canada and Global Affairs Canada, gave Foqus a platform to present its flagship product, DeepFoqus‑Accelerate, a quantum‑enhanced AI system that speeds up magnetic resonance imaging (MRI) workflows. By engaging health‑care providers, co‑development partners, and investors in Helsinki and Stockholm, Foqus is positioning itself for a broader European rollout.

DeepFoqus‑Accelerate: Quantum‑AI for Faster MRI

DeepFoqus‑Accelerate combines quantum‑inspired optimization algorithms with deep‑learning models to reduce the computational load of MRI reconstruction. The technology promises:

• Shorter scan times, improving patient comfort and throughput.
• Lower hardware requirements, making MRI more accessible to smaller hospitals.
• Enhanced image quality, supporting more accurate diagnostics.

While the system remains a prototype, early pilots in Canada have shown up to a 30 % reduction in processing time compared with conventional AI pipelines. The European demonstrations focused on how the solution can integrate with existing scanner hardware and hospital IT stacks, a key concern for potential adopters.

Strategic Benefits of the Nordic Outreach

1. Alignment with NATO‑Allied Quantum Strategies

Finland and Sweden have recently accelerated their national quantum agendas, investing in research hubs and public‑private partnerships. By entering these markets, Foqus taps into a supportive policy environment and gains visibility among governments that are actively seeking quantum‑enabled health technologies.

2. Access to Regional Innovation Ecosystems

Both Helsinki and Stockholm host vibrant health‑tech clusters, including companies specializing in medical imaging, data analytics, and regulatory consulting. One‑on‑one meetings allowed Foqus to identify co‑development partners that could help localize DeepFoqus‑Accelerate for European standards (e.g., CE marking, GDPR compliance).

3. Funding and Collaboration Pathways

The trade mission highlighted available funding streams such as the European Union’s Horizon Europe programme and national grants for quantum‑health initiatives. Foqus representatives discussed joint‑venture structures that could leverage these sources, reducing the financial risk of market entry.

Next Steps for Foqus in Europe

• Pilot Deployments: Secure at least two pilot sites in Finnish or Swedish hospitals by mid‑2024 to generate real‑world performance data.
• Regulatory Roadmap: Work with local regulatory consultants to map the CE certification process and align data‑privacy practices with GDPR.
• Partnership Agreements: Formalize collaborations with regional imaging equipment manufacturers and AI research labs to co‑develop next‑generation modules.
• Scaling Strategy: Use the Nordic pilots as reference cases for broader EU expansion, targeting markets such as Germany and the Netherlands where quantum‑health initiatives are gaining momentum.

Conclusion

Foqus Technologies’ participation in the Canada‑led quantum trade mission has opened concrete pathways for DeepFoqus‑Accelerate in Europe. By aligning with the quantum priorities of Finland and Sweden, the company not only gains market access but also positions itself within a collaborative ecosystem that can accelerate regulatory approval and commercial scaling. The upcoming pilot projects will be critical in demonstrating tangible benefits to European health‑care providers and securing the partnerships needed for a sustained European presence.